Previous Article | Next Article 
Mol Cell Biol. 1988 April; 8(4): 1614-1624
Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1.
S O Freytag
Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor.
ABSTRACT
A broad base of data has implicated a role for the c-myc proto-oncogene in the control of the cell cycle and cell differentiation. To further define the role of myc in these processes, I examined the effect of enforced myc expression on several events that are thought to be important steps leading to the terminally differentiated state: (i) the ability to arrest growth in G0/G1, (ii) the ability to replicate the genome upon initiation of the differentiation program, and (iii) the ability to lose responsiveness to mitogens and withdraw from the cell cycle. 3T3-L1 preadipocyte cell lines expressing various levels of myc mRNA were established by transfection with a recombinant myc gene under the transcriptional control of the Rous sarcoma virus (RSV) promoter. Cells that expressed high constitutive levels of pRSVmyc mRNA arrested in G0/G1 at densities similar to those of normal cells at confluence. Upon initiation of the differentiation program, such cells traversed the cell cycle with kinetics similar to those of normal cells and subsequently arrested in G0/G1. Thus, enforced expression of myc had no effect on the ability of cells to arrest growth in G0/G1 or to replicate the genome upon initiation of the differentiation program. Cells were then tested for their ability to reenter the cell cycle upon exposure to high concentrations of serum and for their capacity to differentiate. In contrast to normal cells, cells expressing high constitutive levels of myc RNA reentered the cell cycle when challenged with 30% serum and failed to terminally differentiate. The block to differentiation could be reversed by high expression of myc antisense RNA, showing that the induced block was specifically due to enforced expression of pRSVmyc. These findings indicate that 3T3-L1 preadipocytes enter a specific state in G0/G1 after treatment with differentiation inducers, into which cells expressing high constitutive levels of myc RNA are precluded from entering. I propose that myc acts as a molecular switch and directs cells to a pathway that can lead to continued proliferation or to terminal differentiation.
Mol Cell Biol. 1988 April; 8(4): 1614-1624
This article has been cited by other articles:
-
Lidonnici, M. R., Corradini, F., Waldron, T., Bender, T. P., Calabretta, B.
(2008). Requirement of c-Myb for p210BCR/ABL-dependent transformation of hematopoietic progenitors and leukemogenesis. Blood
111: 4771-4779
[Abstract]
[Full Text]
-
Moneo, V., Serelde, B. G., Leal, J. F.M., Blanco-Aparicio, C., Diaz-Uriarte, R., Aracil, M., Tercero, J. C., Jimeno, J., Carnero, A.
(2007). Levels of p27kip1 determine Aplidin sensitivity. Molecular Cancer Therapeutics
6: 1310-1316
[Abstract]
[Full Text]
-
Secombe, J., Li, L., Carlos, L., Eisenman, R. N.
(2007). The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev.
21: 537-551
[Abstract]
[Full Text]
-
Patel, J. H., McMahon, S. B.
(2007). BCL2 Is a Downstream Effector of MIZ-1 Essential for Blocking c-MYC-induced Apoptosis. J. Biol. Chem.
282: 5-13
[Abstract]
[Full Text]
-
Blakely, C. M., Sintasath, L., D'Cruz, C. M., Hahn, K. T., Dugan, K. D., Belka, G. K., Chodosh, L. A.
(2005). Developmental stage determines the effects of MYC in the mammary epithelium. Development
132: 1147-1160
[Abstract]
[Full Text]
-
Nilsson, J. A., Nilsson, L. M., Keller, U., Yokota, Y., Boyd, K., Cleveland, J. L.
(2004). Id2 Is Dispensable for Myc-Induced Lymphomagenesis. Cancer Res.
64: 7296-7301
[Abstract]
[Full Text]
-
Rosato, R. R., Almenara, J. A., Yu, C., Grant, S.
(2004). Evidence of a Functional Role for p21WAF1/CIP1 Down-Regulation in Synergistic Antileukemic Interactions between the Histone Deacetylase Inhibitor Sodium Butyrate and Flavopiridol. Mol. Pharmacol.
65: 571-581
[Abstract]
[Full Text]
-
Takai, N., Desmond, J. C., Kumagai, T., Gui, D., Said, J. W., Whittaker, S., Miyakawa, I., Koeffler, H. P.
(2004). Histone Deacetylase Inhibitors Have a Profound Antigrowth Activity in Endometrial Cancer Cells. Clin. Cancer Res.
10: 1141-1149
[Abstract]
[Full Text]
-
Rosato, R. R., Almenara, J. A., Dai, Y., Grant, S.
(2003). Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells. Molecular Cancer Therapeutics
2: 1273-1284
[Abstract]
[Full Text]
-
Rosato, R. R., Almenara, J. A., Grant, S.
(2003). The Histone Deacetylase Inhibitor MS-275 Promotes Differentiation or Apoptosis in Human Leukemia Cells through a Process Regulated by Generation of Reactive Oxygen Species and Induction of p21CIP1/WAF1 1. Cancer Res.
63: 3637-3645
[Abstract]
[Full Text]
-
Cartee, L., Maggio, S. C., Smith, R., Sankala, H. M., Dent, P., Grant, S.
(2003). Protein Kinase C-dependent Activation of the Tumor Necrosis Factor Receptor-mediated Extrinsic Cell Death Pathway Underlies Enhanced Apoptosis in Human Myeloid Leukemia Cells Exposed to Bryostatin 1 and Flavopiridol. Molecular Cancer Therapeutics
2: 83-93
[Abstract]
[Full Text]
-
Zheng, R., Friedman, A. D., Small, D.
(2002). Targeted inhibition of FLT3 overcomes the block to myeloid differentiation in 32Dcl3 cells caused by expression of FLT3/ITD mutations. Blood
100: 4154-4161
[Abstract]
[Full Text]
-
Demeterco, C., Itkin-Ansari, P., Tyrberg, B., Ford, L. P., Jarvis, R. A., Levine, F.
(2002). c-Myc Controls Proliferation Versus Differentiation in Human Pancreatic Endocrine Cells. J. Clin. Endocrinol. Metab.
87: 3475-3485
[Abstract]
[Full Text]
-
Rosato, R. R., Almenara, J. A., Cartee, L., Betts, V., Chellappan, S. P., Grant, S.
(2002). The Cyclin-dependent Kinase Inhibitor Flavopiridol Disrupts Sodium Butyrate-induced p21WAF1/CIP1 Expression and Maturation while Reciprocally Potentiating Apoptosis in Human Leukemia Cells. Molecular Cancer Therapeutics
1: 253-266
[Abstract]
[Full Text]
-
Nakajima, H., Ihle, J. N.
(2001). Granulocyte colony-stimulating factor regulates myeloid differentiation through CCAAT/enhancer-binding protein {epsilon}. Blood
98: 897-905
[Abstract]
[Full Text]
-
Hellmann, G. M., Fields, W. R., Doolittle, D. J.
(2001). Gene Expression Profiling of Cultured Human Bronchial Epithelial and Lung Carcinoma Cells. Toxicol Sci
61: 154-163
[Abstract]
[Full Text]
-
Pennington, K. N., Taylor, J. A., Bren, G. D., Paya, C. V.
(2001). I{kappa}B Kinase-Dependent Chronic Activation of NF-{kappa}B Is Necessary for p21WAF1/Cip1 Inhibition of Differentiation-Induced Apoptosis of Monocytes. Mol. Cell. Biol.
21: 1930-1941
[Abstract]
[Full Text]
-
Cartee, L., Wang, Z., Decker, R. H., Chellappan, S. P., Fusaro, G., Hirsch, K. G., Sankala, H. M., Dent, P., Grant, S.
(2001). The Cyclin-dependent Kinase Inhibitor (CDKI) Flavopiridol Disrupts Phorbol 12-Myristate 13-Acetate-induced Differentiation and CDKI Expression while Enhancing Apoptosis in Human Myeloid Leukemia Cells. Cancer Res.
61: 2583-2591
[Abstract]
[Full Text]
-
Ntambi, J. M., Young-Cheul, K.
(2000). Adipocyte Differentiation and Gene Expression. J. Nutr.
130
: 3122S-3126S
[Abstract]
[Full Text]
-
SHI, H., HALVORSEN, Y.-D., ELLIS, P. N., WILKISON, W. O., ZEMEL, M. B.
(2000). Role of intracellular calcium in human adipocyte differentiation. Physiol. Genomics
3: 75-82
[Abstract]
[Full Text]
-
Barrera-Hernandez, G., Cultraro, C. M., Pianetti, S., Segal, S.
(2000). Mad1 Function Is Regulated through Elements within the Carboxy Terminus. Mol. Cell. Biol.
20: 4253-4264
[Abstract]
[Full Text]
-
Quéva, C., McArthur, G. A., Ramos, L. S., Eisenman, R. N.
(1999). Dwarfism and Dysregulated Proliferation in Mice Overexpressing the MYC Antagonist MAD1. Cell Growth Differ.
10: 785-796
[Abstract]
[Full Text]
-
Sarbia, M., Loberg, C., Wolter, M., Arjumand, J., Heep, H., Reifenberger, G., Gabbert, H. E.
(1999). Expression of Bcl-2 and Amplification of c-myc Are Frequent in Basaloid Squamous Cell Carcinomas of the Esophagus. Am. J. Pathol.
155: 1027-1032
[Abstract]
[Full Text]
-
Bahram, F., Wu, S., Oberg, F., Luscher, B., Larsson, L.-G.
(1999). Posttranslational Regulation of Myc Function in Response to Phorbol Ester/Interferon-gamma -Induced Differentiation of v-Myc-Transformed U-937 Monoblasts. Blood
93: 3900-3912
[Abstract]
[Full Text]
-
Lee, T. C., Ziff, E. B.
(1999). Mxi1 Is a Repressor of the c-myc Promoter and Reverses Activation by USF. J. Biol. Chem.
274: 595-606
[Abstract]
[Full Text]
-
Dang, C. V.
(1999). c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism. Mol. Cell. Biol.
19: 1-11
[Full Text]
-
Yeilding, N. M., Procopio, W. N., Rehman, M. T., Lee, W. M. F.
(1998). c-myc mRNA Is Down-regulated during Myogenic Differentiation by Accelerated Decay That Depends on Translation of Regulatory Coding Elements. J. Biol. Chem.
273: 15749-15757
[Abstract]
[Full Text]
-
Facchini, L., Penn, L. Z.
(1998). The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J.
12: 633-651
[Abstract]
[Full Text]
-
Mercurius, K. O., Morla, A. O.
(1998). Inhibition of Vascular Smooth Muscle Cell Growth by Inhibition of Fibronectin Matrix Assembly. Circ. Res.
82: 548-556
[Abstract]
[Full Text]
-
Sommer, A., Bousset, K., Kremmer, E., Austen, M., Luscher, B.
(1998). Identification and Characterization of Specific DNA-binding Complexes Containing Members of the Myc/Max/Mad Network of Transcriptional Regulators. J. Biol. Chem.
273: 6632-6642
[Abstract]
[Full Text]
-
Boer, J., Bonten-Surtel, J., Grosveld, G.
(1998). Overexpression of the Nucleoporin CAN/NUP214 Induces Growth Arrest, Nucleocytoplasmic Transport Defects, and Apoptosis. Mol. Cell. Biol.
18: 1236-1247
[Abstract]
[Full Text]
-
Vaziri, C., Faller, D. V.
(1996). Down-regulation of Platelet-derived Growth Factor Receptor Expression during Terminal Differentiation of 3T3-L1 Pre-adipocyte Fibroblasts. J. Biol. Chem.
271: 13642-13648
[Abstract]
[Full Text]
-
Ayer, D E, Eisenman, R N
(1993). A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation.. Genes Dev.
7: 2110-2119
[Abstract]
-
Smyth, M., Sparks, R., Wharton, W
(1993). Proadipocyte cell lines: models of cellular proliferation and differentiation. J. Cell Sci.
106: 1-9
-
Charron, J, Malynn, B A, Fisher, P, Stewart, V, Jeannotte, L, Goff, S P, Robertson, E J, Alt, F W
(1992). Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene.. Genes Dev.
6: 2248-2257
[Abstract]
-
Gallo, A, Benusiglio, E, Bonapace, I M, Feliciello, A, Cassano, S, Garbi, C, Musti, A M, Gottesman, M E, Avvedimento, E V
(1992). v-ras and protein kinase C dedifferentiate thyroid cells by down-regulating nuclear cAMP-dependent protein kinase A.. Genes Dev.
6: 1621-1630
[Abstract]
-
Freytag, S. O., Geddes, T. J.
(1992). Reciprocal Regulation of Adipogenesis by Myc and C/EBPagr. Science
256: 379-382
[Abstract]
-
Avvedimento, V E, Musti, A M, Ueffing, M, Obici, S, Gallo, A, Sanchez, M, DeBrasi, D, Gottesman, M E
(1991). Reversible inhibition of a thyroid-specific trans-acting factor by Ras.. Genes Dev.
5: 22-28
[Abstract]
-
Luscher, B, Eisenman, R N
(1990). New light on Myc and Myb. Part I. Myc.. Genes Dev.
4: 2025-2035
-
Spencer, C A, LeStrange, R C, Novak, U, Hayward, W S, Groudine, M
(1990). The block to transcription elongation is promoter dependent in normal and Burkitt's lymphoma c-myc alleles.. Genes Dev.
4: 75-88
[Abstract]
-
Kim, S., Li, Q., Dang, C. V., Lee, L. A.
(2000). Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. Proc. Natl. Acad. Sci. USA
97: 11198-11202
[Abstract]
[Full Text]
Copyright © 1988 by the American Society for Microbiology. All rights reserved.